PharmaCorp RX Inc. acquires PharmaChoice

PharmaCorp Rx Inc., a Canadian firm focused on pharmacy acquisitions, has agreed to purchase a PharmaChoice Canada bannered pharmacy in Morrisburg, Ontario. The transaction, valued at approximately $8.2 million, marks a strategic step in PharmaCorp's expansion within the province. This acquisition aligns with the company's objective to increase its presence in Eastern Canada and demonstrates its ability to translate non-binding letters of intent into definitive agreements.

Under the terms of the agreement, PharmaCorp will acquire a 100% interest in the Morrisburg pharmacy from an independent vendor group. This addition will bring PharmaCorp's total store count to 15, including other PharmaChoice Canada pharmacies acquired earlier in the year. The acquisition transaction will be financed using PharmaCorp's existing cash resources, and no third-party finder’s fees are associated with this deal. Completion of the acquisition is anticipated within approximately 60 days, pending customary conditions, including the Ontario College of Pharmacists' approval.

PharmaCorp's Executive Chair, Alan Simpson, emphasized the acquisition as evidence of the company's disciplined approach to capital allocation and strategic growth. The company aims to efficiently integrate the new pharmacy into its network while preserving existing patient relationships and ensuring a smooth transition through continued management by the current pharmacist during the interim.

This transaction is part of PharmaCorp's broader strategy to establish a national network of community pharmacies. By focusing on disciplined acquisition multiples, PharmaCorp seeks to enhance shareholder value through accretive growth. The firm's strategy includes expanding its acquisitions under the PharmaChoice Canada banner, supporting pharmacist-led ownership, and facilitating succession for retiring pharmacy owners.

As the pharmacy sector faces growing consolidation pressures, such acquisitions are critical for companies like PharmaCorp to consolidate market share and streamline operations. PharmaCorp's decision to fund the acquisition from its current reserves indicates a prudent financial strategy amidst ongoing industry dynamics. Looking ahead, the successful completion of this acquisition could position PharmaCorp to pursue further expansion opportunities across Canada.